Clinical trial
Bleeding Patterns in Sequential and Continuous Progesterone Supplementation in Adolescents With Turner Syndrome: A Non-randomized Prospective Trial (The BOOST Study)
NCT06834594 is registered in ClinicalTrials.gov with Children's Mercy Hospital Kansas City as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Bleeding Patterns in Sequential and Continuous Progesterone Supplementation in Adolescents With Turner Syndrome: A Non-randomized Prospective Trial (The BOOST Study)
- Lead sponsor
- Children's Mercy Hospital Kansas City
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- July 31, 2025
- Completion date
- July 31, 2028
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
primary ovarian insufficiency (poi), turner syndrome